Guaifenesin
- Product NDC
- 60687-852
- 11-digit product format
- 606870852
- Labeler code
- 60687
- Product ID
- 60687-852_24b1b6f4-c113-8adc-e063-6394a90a546c
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Guaifenesin
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- American Health Packaging
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2024-10-20
- Substance
- GUAIFENESIN
- Active strength
- 100 mg/5mL
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Guaifenesin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GUAIFENESIN | 100 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 495W7451VQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 310604 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2fd702ea-3069-472c-b99e-c527f1375705 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e2db08c6-133f-4f4f-afb4-e90a2418d6f6 | Product name | 1 | 20230320 |
| ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906 | Product name | 7 | 20210625 |
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| 11ed6f83-cdd2-4637-8379-b1a1d3ae3cde | Product name | 1 | 20181101 |
| 86c45a79-b9f0-4476-a27c-6e10db098497 | Product name | 1 | 20180125 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 4fe95224-f543-4dbb-9445-8cca122b48c8 | Product name | 1 | 20150609 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 106ff02a-57e1-4c4c-a307-fd582ff4e311 | Product name | 1 | 20150212 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60687-852-17 | Guaifenesin | 10 in 1 CASE | SOLUTION | 10 | 1 | |
| 60687-852-40 | Guaifenesin | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 1 | |
| 60687-852-46 | Guaifenesin | 10 in 1 TRAY | SOLUTION | 10 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60687-852-17 | ML - Milliliter | 60687-852 | 4a65c2b5-de11-422b-83ae-f0f3e9d71468 | 1 | 2024-11-05 |
| 60687-852-40 | ML - Milliliter | 60687-852 | 459738a7-6ab0-4aa9-b321-6b3515eb703e | 1 | 2024-11-05 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vicks Sinex Severe All in One Sinus | ACETAMINOPHEN, PHENYLEPHRINE HCL | The Procter & Gamble Manufacturing Company | 9a106398-6d9d-2146-e053-2995a90a3fdf | 2026-10-02 | Warnings | M012 |
| Vicks Sinex Severe All in One Sinus Mucus | ACETAMINOPHEN, PHENYLEPHRINE HCL, GUAIFENESIN | The Procter & Gamble Manufacturing Company | 9a106291-edda-2135-e053-2995a90a44fd | 2026-10-02 | Warnings | M012 |
| Vicks Sinex SEVERE CONGESTION | OXYMETAZOLINE HYDROCHLORIDE | Procter & Gamble Manufacturing GmbH | 4644c4ae-9607-d404-e063-6294a90aca24 | 2026-10-02 | Warnings | M012 |
| VICKS SINEX SEVERE CONGESTION ORIGINAL Ultra Fine Mist | OXYMETAZOLINE HYDROCHLORIDE | Procter & Gamble Manufacturing GmbH, | 4645336e-40d8-89e6-e063-6294a90a7655 | 2026-10-02 | Warnings | M012 |
| Vicks Sinex SEVERE CONGESTION MOISTURIZING ULTRA FINE MIST | OXYMETAZOLINE HYDROCHLORIDE | Procter & Gamble Manufacturing GmbH | 464534ee-15f8-3af8-e063-6394a90a3f18 | 2026-10-02 | Warnings | M012 |
| Vicks SINEX SEVERE CONGESTION VapoCOOL ULTRA FINE MIST | OXYMETAZOLINE HYDROCHLORIDE | Procter & Gamble Manufacturing GmbH | 464550b3-5970-aca5-e063-6294a90a5954 | 2026-10-02 | Warnings | M012 |
| Vicks Jarabe Cough Congestion | DEXTROMETHORPHAN HBR AND GUAIFENESIN | The Procter & Gamble Manufacturing Company | a0fa86d4-e53b-cbf4-e053-2995a90a1396 | 2026-10-02 | Warnings | M012 |
| Vicks DayQuil Cough DM plus Congestion | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN AND PHENYLEPHRINE HYDROCHLORIDE | The Procter & Gamble Manufacturing Company | c48359ee-6e52-841d-e053-2a95a90ae293 | 2026-10-02 | Warnings | M012 |
| NyQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, AND PHENYLEPHRINE HYDROCHLORIDE | The Procter & Gamble Manufacturing Company | ef6df67c-0afa-4825-e053-2995a90aced9 | 2026-10-02 | Warnings | M012 |
| DayQuil and NyQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | The Procter & Gamble Manufacturing Company | fbd53e5f-bc03-75b4-e053-6394a90af028 | 2026-10-02 | Warnings | M012 |
| DayQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION | ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE, AND GUAIFENESIN | The Procter & Gamble Manufacturing Company | ef6e8503-d268-291b-e053-2995a90aec8f | 2026-10-02 | Warnings | M012 |
| VICKS DayQuil SEVERE NyQuil SEVERE HONEY FLAVOR COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | fd03769c-2fd6-1c22-e053-6394a90a12f6 | 2026-10-02 | Warnings | M012 |
| VICKS DayQuil SEVERE HONEY FLAVOR COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Procter & Gamble Manufacturing Company | 04c9ccda-64aa-0cd0-e063-6394a90a32bf | 2026-10-02 | Warnings | M012 |
| VICKS NyQuil SEVERE HONEY FLAVOR COLD and FLU | ACETAMINOPHEN, DEXTROMETHROPHAN, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Procter & Gamble Manufacturing Company | 04ca1e9c-f297-cbd6-e063-6294a90a3739 | 2026-10-02 | Warnings | M012 |
| Vicks DayQuil Severe Honey Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Procter & Gamble Manufacturing Company | 1b579102-9eac-1b2f-e063-6394a90add0a | 2026-10-02 | Warnings | M012 |
| Vicks NyQuil Severe Honey Cold and Flu | ACETAMINOPHEN, DEXTROMETHROPHAN, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Procter & Gamble Manufacturing Company | d3b2ca47-d51e-f69f-e053-2995a90a587e | 2026-10-02 | Warnings | M012 |
| VICKS DayQuil NyQuil SEVERE HONEY COLD and FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL AND DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 25a092c3-a9cb-6314-e063-6294a90a5297 | 2026-10-02 | Warnings | M012 |
| Vicks DayQuil HOT REMEDY Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | Procter & Gamble Manufactura S de RL de CV | 424cf178-39cc-b37c-e063-6394a90a990b | 2026-10-02 | Warnings | M012 |
| Vicks NyQuil HOT REMEDY Cold and Flu | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | Procter & Gamble Manufactura S de RL de CV | 4535d4fe-9de7-f2c6-e063-6394a90a944a | 2026-10-02 | Warnings | M012 |
| Vicks DayQuil NyQuil HOT REMEDY Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DIPHENHYDRAMINE HCL | Procter & Gamble Manufactura S de RL de CV | 457180c9-87ea-5b52-e063-6294a90a7e9d | 2026-10-02 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 310604 | guaiFENesin 100 MG in 5 mL Oral Solution | PSN | 2fd702ea-3069-472c-b99e-c527f1375705 | 1 |
| 310604 | guaifenesin 20 MG/ML Oral Solution | SCD | 2fd702ea-3069-472c-b99e-c527f1375705 | 1 |
| 310604 | guaifenesin 100 MG per 5 ML Oral Solution | SY | 2fd702ea-3069-472c-b99e-c527f1375705 | 1 |
| 310604 | guaifenesin 100 MG per 5 ML Oral Syrup | SY | 2fd702ea-3069-472c-b99e-c527f1375705 | 1 |
| 310604 | guaifenesin 200 MG per 10 ML Oral Solution | SY | 2fd702ea-3069-472c-b99e-c527f1375705 | 1 |
| 310604 | guaifenesin 300 MG per 15 ML Oral Solution | SY | 2fd702ea-3069-472c-b99e-c527f1375705 | 1 |
| 310604 | guaifenesin 400 MG per 20 ML Oral Solution | SY | 2fd702ea-3069-472c-b99e-c527f1375705 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 60687-852-17 | 60687085217 | 10 TRAY in 1 CASE (60687-852-17) / 10 CUP, UNIT-DOSE in 1 TRAY (60687-852-46) / 5 mL in 1 CUP, UNIT-DOSE (60687-852-40) | 10 tray | 2024-10-20 | No | No | Current |
| 60687-852-40 | 60687085240 | 5 mL in 1 CUP, UNIT-DOSE | 5 ml | Historical | |||
| 60687-852-46 | 60687085246 | 10 in 1 TRAY | Historical |